Who funds brain tumour research?
We count 61 funded brain tumour projects, active between 2020 and 2032, from 6 funders. The most came from EU · MSCA (21 projects), EU · ERC (20 projects) and EU · EIC (5 projects). The median award is $1.6M, across the 59 of 61 projects that list an amount.
- Funded projects
- 61
- Funders
- 6
- Median award
- $1.6M
- Open calls now
- 1
Top funders of brain tumour research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| EU · MSCA | 21 | 34% | $272K |
| EU · ERC | 20 | 33% | $1.6M |
| EU · EIC | 5 | 8% | $3M |
| EU · Health | 4 | 7% | $9.5M |
| NIH · NCI | 3 | 5% | $4.2M |
| Wellcome | 3 | 5% | — |
| EU · Widening participation and spreading excellence | 2 | 3% | — |
| FDA · Food and Drug Administration | 1 | 2% | — |
| NSF · MPS | 1 | 2% | — |
| USDA | 1 | 2% | — |
Projects whose title or summary mentions brain tumour. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open brain tumour funding calls
1 open call mentions brain tumour today.
-
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
National Institutes of HealthUp to $700,000Deadline: January 11, 2027 ·
Funded brain tumour projects
A sample, latest start first, at most three per program.
-
Collaborative Research: FDT-BioTech: Mathematical Foundations of Adaptable Digital Twins for Glioblastoma
NSF · MPS · $547,876 · ends 2029
-
Understanding the role of tumor microenvironment in low grade glioma progression to malignancy
NIH · NCI · $4,206,752 · ends 2029
-
Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma
FDA · Food and Drug Administration · $3,218,733 · ends 2029
-
Magnetic Resonance Fingerprinting of Glutamate Metabolism for Guiding Glioma Cancer Care
NIH · NCI · $3,155,815 · ends 2029
-
This project aims to explore the potential of natural plant compounds, called phytochemicals, in treating two challenging types of cancer…
USDA · $299,850 · ends 2028
-
Investigating the role of fibroblast-like cells in shaping the glioblastoma tumour microenvironment
Wellcome · ends 2028
-
Transcriptional Regulation of Glioma Cell State Transitions and Microenviroment Interactions
Wellcome · ends 2027
-
Investigating the mechanisms driving cancer cell DORMancy and REcurrence in glioblastoma
EU · MSCA · €292,119 · 2027–2029 · UNIVERSITE DE LAUSANNE
-
Investigating the role of tRNA-dependent translational control in the onset and progression of Glioblastoma.
EU · MSCA · €226,421 · 2027–2029 · INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
-
Multifunctional Nanogel for Prolonged Immunoregulation and ECM Remodelling in Post-Surgical Diffuse Intrinsic Pontine Glioma: Organ-on-Chip Model
EU · MSCA · €207,758 · 2027–2029 · UNIVERZITA PALACKEHO V OLOMOUCI
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “glioblastoma or glioma”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with brain tumour calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free